Detalles de la búsqueda
1.
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study.
Oncologist;
29(3): e372-e381, 2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37796838
2.
The role of blood cholesterol quality in patients with advanced cancer receiving immune checkpoint inhibitors.
Cancer Immunol Immunother;
72(7): 2127-2135, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36828963
3.
Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer.
Curr Oncol Rep;
25(9): 1017-1029, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37378881
4.
Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study.
Oncologist;
27(9): e723-e730, 2022 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35815922
5.
Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer.
Curr Treat Options Oncol;
22(8): 69, 2021 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34110510
6.
Association of Baseline Tumor-Specific Neoantigens and CD8+ T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors.
JCO Precis Oncol;
8: e2300439, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38330262
7.
Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer.
J Clin Oncol;
42(11): 1311-1321, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38207230
8.
Activating point mutations in the MET kinase domain represent a unique molecular subset of lung cancer and other malignancies targetable with MET inhibitors.
Cancer Discov;
2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38564707
9.
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research.
Clin Lung Cancer;
25(2): 190-195, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38262770
10.
Hemoglobin and Neutrophil Count as Prognostic Factors in Cholangiocarcinoma Patients in 2nd Line Treatment Setting: Results from a Small Monocentric Retrospective Study.
Curr Oncol;
30(1): 1032-1045, 2023 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36661728
11.
Current Evidence and Future Perspectives about the Role of PARP Inhibitors in the Treatment of Thoracic Cancers.
Onco Targets Ther;
16: 585-613, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37485307
12.
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment.
Dig Liver Dis;
55(5): 655-660, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36513569
13.
Amplification of Wild-Type RET Represents a Novel Molecular Subtype of Several Cancer Types With Clinical Response to Selpercatinib.
JCO Precis Oncol;
7: e2300295, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37972337
14.
Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC.
Nat Commun;
14(1): 4238, 2023 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37454214
15.
Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort study.
J Immunother Cancer;
11(7)2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37487667
16.
Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer.
J Immunother Cancer;
11(11)2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37914383
17.
Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC.
J Thorac Oncol;
18(6): 731-743, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36775193
18.
Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLC.
J Thorac Oncol;
18(11): 1524-1537, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37247843
19.
Clinicopathologic, Genomic, and Immunophenotypic Landscape of ATM Mutations in Non-Small Cell Lung Cancer.
Clin Cancer Res;
29(13): 2540-2550, 2023 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37097610
20.
Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer.
Clin Cancer Res;
29(21): 4408-4418, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37432985